tiprankstipranks
Trending News
More News >
TransMedics Group Inc (TMDX)
NASDAQ:TMDX
US Market
Advertisement

TransMedics Group (TMDX) Stock Statistics & Valuation Metrics

Compare
1,488 Followers

Total Valuation

TransMedics Group has a market cap or net worth of $3.56B. The enterprise value is $4.12B.
Market Cap$3.56B
Enterprise Value$4.12B

Share Statistics

TransMedics Group has 33,833,790 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding33,833,790
Owned by Insiders3.55%
Owned by Institutions0.41%

Financial Efficiency

TransMedics Group’s return on equity (ROE) is 0.16 and return on invested capital (ROIC) is 4.98%.
Return on Equity (ROE)0.16
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)4.98%
Return on Capital Employed (ROCE)0.05
Revenue Per Employee606.51K
Profits Per Employee48.71K
Employee Count728
Asset Turnover0.55
Inventory Turnover3.85

Valuation Ratios

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio77.3
PS Ratio0.00
PB Ratio14.62
Price to Fair Value9.06
Price to FCF-61.77
Price to Operating Cash Flow78.82
PEG Ratio2.18

Income Statement

In the last 12 months, TransMedics Group had revenue of 441.54M and earned 35.46M in profits. Earnings per share was 1.07.
Revenue441.54M
Gross Profit262.08M
Operating Income37.50M
Pretax Income35.78M
Net Income35.46M
EBITDA69.95M
Earnings Per Share (EPS)1.07

Cash Flow

In the last 12 months, operating cash flow was 49.38M and capital expenditures -112.61M, giving a free cash flow of -63.23M billion.
Operating Cash Flow49.38M
Free Cash Flow-63.23M
Free Cash Flow per Share-1.87

Dividends & Yields

TransMedics Group pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.43
52-Week Price Change-24.27%
50-Day Moving Average124.77
200-Day Moving Average91.81
Relative Strength Index (RSI)35.06
Average Volume (3m)916.13K

Important Dates

TransMedics Group upcoming earnings date is Nov 11, 2025, After Close (Confirmed).
Last Earnings DateJul 30, 2025
Next Earnings DateNov 11, 2025
Ex-Dividend Date

Financial Position

TransMedics Group as a current ratio of 8.30, with Debt / Equity ratio of 194.67%
Current Ratio8.30
Quick Ratio7.52
Debt to Market Cap0.25
Net Debt to EBITDA2.60
Interest Coverage Ratio2.60

Taxes

In the past 12 months, TransMedics Group has paid 316.00K in taxes.
Income Tax316.00K
Effective Tax Rate<0.01

Enterprise Valuation

TransMedics Group EV to EBITDA ratio is 32.22, with an EV/FCF ratio of -27.84.
EV to Sales5.10
EV to EBITDA32.22
EV to Free Cash Flow-27.84
EV to Operating Cash Flow46.18

Balance Sheet

TransMedics Group has $310.14M in cash and marketable securities with $518.41M in debt, giving a net cash position of $208.27M billion.
Cash & Marketable Securities$310.14M
Total Debt$518.41M
Net Cash$208.27M
Net Cash Per Share$6.16
Tangible Book Value Per Share$6.47

Margins

Gross margin is 59.45%, with operating margin of 8.49%, and net profit margin of 8.03%.
Gross Margin59.45%
Operating Margin8.49%
Pretax Margin8.10%
Net Profit Margin8.03%
EBITDA Margin15.84%
EBIT Margin11.37%

Analyst Forecast

The average price target for TransMedics Group is $140.57, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$140.57
Price Target Upside33.57% Upside
Analyst ConsensusModerate Buy
Analyst Count9
Revenue Growth Forecast64.43%
EPS Growth Forecast

Scores

Smart Score7
AI Score68
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis